Literature DB >> 9226148

Juvenile myelomonocytic leukemia.

M Aricò1, A Biondi, C H Pui.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9226148

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  36 in total

1.  Choroidal infiltration in juvenile myelomonocytic leukaemia.

Authors:  G C Chang; D M Moshfeghi; D M Alcorn
Journal:  Br J Ophthalmol       Date:  2006-08       Impact factor: 4.638

2.  Shp2E76K mutant confers cytokine-independent survival of TF-1 myeloid cells by up-regulating Bcl-XL.

Authors:  Yuan Ren; Zhengming Chen; Liwei Chen; Nicholas T Woods; Gary W Reuther; Jin Q Cheng; Hong-gang Wang; Jie Wu
Journal:  J Biol Chem       Date:  2007-10-17       Impact factor: 5.157

3.  Cytogenetics and clinical features of pediatric myelodysplastic syndrome in Japan.

Authors:  Koichi Moriwaki; Atsushi Manabe; Takeshi Taketani; Akira Kikuchi; Tatsutoshi Nakahata; Yasuhide Hayashi
Journal:  Int J Hematol       Date:  2014-09-27       Impact factor: 2.490

Review 4.  Translational hematology.

Authors:  Klaus Geissler
Journal:  Wien Med Wochenschr       Date:  2014-09-10

5.  Identification of an immunogenic CD8+ T-cell epitope derived from gamma-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemia.

Authors:  Naoto Hirano; Marcus O Butler; Zhinan Xia; Alla Berezovskaya; Andrew P Murray; Sascha Ansén; Seiji Kojima; Lee M Nadler
Journal:  Blood       Date:  2006-06-15       Impact factor: 22.113

6.  PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase.

Authors:  Rebecca J Chan; Gen-Sheng Feng
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

7.  Granulocytic sarcoma presenting with severe adenopathy (cervical lymph nodes, tonsils, and adenoids) in a child with juvenile myelomonocytic leukemia and successful treatment with allogeneic bone marrow transplantation.

Authors:  Toshihiko Imamura; Satoshi Matsuo; Takao Yoshihara; Tomohiro Chiyonobu; Kanako Mori; Hiroyuki Ishida; Yasutaka Nishimura; Yasuo Kasubuchi; Mayumi Naya; Akira Morimoto; Shigeyoshi Hibi; Shinsaku Imashuku
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

8.  KMT2A-rearranged infantile acute myeloid leukemia masquerading as juvenile myelomonocytic leukemia.

Authors:  Takuyo Kanayama; Toshihiko Imamura; Yasuhiro Kawabe; Shinya Osone; Junko Tahara; Fuminori Iwasaki; Naoyuki Miyagawa; Hiroaki Goto; Shinsaku Imashuku; Hajime Hosoi
Journal:  Int J Hematol       Date:  2018-08-24       Impact factor: 2.490

9.  Juvenile myelomonocytic leukemia.

Authors:  Neha Sethi; Shivani Kushwaha; Bhawana Dhingra; Mukta Pujani; Jagdish Chandra; Shailaja Shukla
Journal:  Indian J Hematol Blood Transfus       Date:  2012-06-10       Impact factor: 0.900

10.  Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia.

Authors:  Sophie Archambeault; Nikki J Flores; Ayami Yoshimi; Christian P Kratz; Miriam Reising; Alexandra Fischer; Peter Noellke; Franco Locatelli; Petr Sedlacek; Christian Flotho; Marco Zecca; Peter D Emanuel; Robert P Castleberry; Charlotte M Niemeyer; Peter Bader; Mignon L Loh
Journal:  Blood       Date:  2007-11-13       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.